MEI Pharma
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $65,297 | $1,457 |
Gross Profit | -86 | -85 | 64,838 | 993 |
EBITDA | -9,743 | -11,845 | 55,368 | -10,982 |
EBIT | -9,829 | -11,930 | 54,909 | -11,080 |
Net Income | -9,127 | -11,063 | 56,374 | -10,029 |
Net Change In Cash | 0 | 0 | 65,297 | 1,457 |
Free Cash Flow | -2,928 | -11,062 | -18,484 | -11,274 |
Cash | 2,368 | 5,174 | 3,372 | 16,906 |
Basic Shares | 6,663 | 6,663 | 6,663 | 6,663 |
Annual Financials
| Values in thousands | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|
Revenue | $48,816 | $40,697 | $25,535 | $28,913 |
Gross Profit | 47,001 | 39,462 | 24,127 | 26,242 |
EBITDA | -37,981 | -95,910 | -87,522 | -1,561 |
EBIT | -39,796 | -97,145 | -87,807 | -1,670 |
Net Income | -31,838 | -54,738 | -50,575 | -46,016 |
Net Change In Cash | 48,816 | 40,697 | 25,535 | 28,913 |
Cost of Revenue | -3,788 | 2,741 | ||
Free Cash Flow | -52,519 | -49,225 | -32,672 | 33,364 |
Cash | 16,906 | 15,740 | 8,543 | 12,331 |
Basic Shares | 6,663 | 6,257 | 5,724 | 4,554 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$2.76 |
2024-03-31 | -$1.37 |
2023-12-31 | -$1.66 |
2023-09-30 | $8.46 |
